share_log

Teachers Retirement System of The State of Kentucky Decreases Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)

Teachers Retirement System of The State of Kentucky Decreases Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)

肯塔基州教師退休制度減少了西部製藥服務公司(紐約證券交易所代碼:WST)的股票頭寸
Defense World ·  2022/09/21 06:31

Teachers Retirement System of The State of Kentucky lessened its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating) by 4.2% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 5,271 shares of the medical instruments supplier's stock after selling 229 shares during the period. Teachers Retirement System of The State of Kentucky's holdings in West Pharmaceutical Services were worth $2,165,000 at the end of the most recent quarter.

肯塔基州教師退休系統公司最近向美國證券交易委員會提交的13F文件顯示,今年第一季度,該公司減持了West Pharmtics Services,Inc.的股票4.2%。該公司在此期間出售了229股後,擁有這家醫療器械供應商的5271股股票。肯塔基州教師退休制度在最近一個季度末,肯塔基州在West Pharmtics Services持有的股份價值2,165,000美元。

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in West Pharmaceutical Services by 1.0% in the first quarter. Vanguard Group Inc. now owns 8,716,312 shares of the medical instruments supplier's stock worth $3,579,876,000 after purchasing an additional 82,459 shares during the period. BlackRock Inc. increased its stake in West Pharmaceutical Services by 8.9% in the fourth quarter. BlackRock Inc. now owns 8,094,288 shares of the medical instruments supplier's stock worth $3,796,302,000 after purchasing an additional 664,275 shares during the period. State Street Corp increased its stake in West Pharmaceutical Services by 1.6% in the fourth quarter. State Street Corp now owns 3,455,709 shares of the medical instruments supplier's stock worth $1,620,762,000 after purchasing an additional 54,510 shares during the period. WCM Investment Management LLC increased its stake in West Pharmaceutical Services by 0.8% in the first quarter. WCM Investment Management LLC now owns 1,526,481 shares of the medical instruments supplier's stock worth $626,941,000 after purchasing an additional 11,655 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its stake in West Pharmaceutical Services by 1.6% in the first quarter. Massachusetts Financial Services Co. MA now owns 741,881 shares of the medical instruments supplier's stock worth $304,698,000 after purchasing an additional 11,569 shares during the period. Hedge funds and other institutional investors own 91.98% of the company's stock.

其他幾家對衝基金和其他機構投資者最近也買賣了該股的股票。先鋒集團(Vanguard Group Inc.)在第一季度增持了西部醫藥服務公司1.0%的股份。先鋒集團現在持有這家醫療器械供應商的8,716,312股股票,價值3,579,876,000美元,在此期間又購買了82,459股。貝萊德股份有限公司在第四季度增持了西部藥業8.9%的股份。貝萊德股份有限公司在此期間增持了664,275股,目前持有這家醫療器械供應商8,094,288股股票,價值3,796,302,000美元。道富集團第四季度增持西部醫藥服務公司1.6%的股份。道富集團目前持有這家醫療器械供應商3,455,709股股票,價值1,620,762,000美元,在此期間又購買了54,510股。WCM Investment Management LLC在第一季度增持了西方醫藥服務公司0.8%的股份。WCM Investment Management LLC現在擁有這家醫療器械供應商1,526,481股股票,價值626,941,000美元,在此期間又購買了11,655股。最後,馬薩諸塞州金融服務公司在第一季度增持了西部藥業1.6%的股份。馬雲目前持有這家醫療器械供應商741,881股股票,價值304,698,000美元。在此期間,馬雲又購買了11,569股。對衝基金和其他機構投資者持有該公司91.98%的股票。

Get
到達
West Pharmaceutical Services
西部藥業服務公司
alerts:
警報:

Insider Activity

內幕活動

In other news, insider Silji Abraham sold 5,374 shares of the firm's stock in a transaction on Monday, August 1st. The stock was sold at an average price of $343.93, for a total transaction of $1,848,279.82. Following the transaction, the insider now owns 3,201 shares in the company, valued at $1,100,919.93. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.60% of the company's stock.

在其他新聞方面,內部人士Silji Abraham在8月1日星期一的一筆交易中出售了5374股該公司股票。股票以343.93美元的平均價格出售,總成交金額為1,848,279.82美元。交易完成後,這位內部人士現在擁有該公司3201股,價值1100,919.93美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的,該文件可通過這個環節。內部人士持有該公司0.60%的股份。

West Pharmaceutical Services Stock Performance

西部醫藥服務公司股票表現

WST stock opened at $263.69 on Wednesday. The company has a quick ratio of 2.41, a current ratio of 3.13 and a debt-to-equity ratio of 0.09. The business's fifty day simple moving average is $311.87 and its two-hundred day simple moving average is $329.79. West Pharmaceutical Services, Inc. has a twelve month low of $261.31 and a twelve month high of $475.00. The firm has a market cap of $19.53 billion, a price-to-earnings ratio of 29.27, a PEG ratio of 1.09 and a beta of 1.18.
週三,WST股價開盤報263.69美元。該公司的速動比率為2.41,流動比率為3.13,債務權益比為0.09。該業務的50日簡單移動均線切入位為311.87美元,200日簡單移動均線切入位為329.79美元。West Pharmtics Services,Inc.的12個月低點為261.31美元,12個月高位為475.00美元。該公司市值為195.3億美元,市盈率為29.27倍,聚乙二醇率為1.09倍,貝塔係數為1.18。

West Pharmaceutical Services (NYSE:WST – Get Rating) last released its earnings results on Thursday, July 28th. The medical instruments supplier reported $2.47 earnings per share for the quarter, topping analysts' consensus estimates of $2.19 by $0.28. The business had revenue of $771.30 million for the quarter, compared to analyst estimates of $754.25 million. West Pharmaceutical Services had a return on equity of 29.08% and a net margin of 23.41%. The business's revenue was up 6.6% compared to the same quarter last year. During the same quarter last year, the firm posted $2.46 earnings per share. Analysts predict that West Pharmaceutical Services, Inc. will post 9.09 earnings per share for the current year.

West Pharmtics Services(紐約證券交易所代碼:WST-GET Rating)最近一次公佈收益結果是在7月28日星期四。這家醫療器械供應商公佈本季度每股收益為2.47美元,比分析師普遍預期的2.19美元高出0.28美元。該業務本季度營收為7.713億美元,而分析師預期為7.5425億美元。西部醫藥服務公司的股本回報率為29.08%,淨利潤率為23.41%。與去年同期相比,該業務的收入增長了6.6%。去年同一季度,該公司公佈的每股收益為2.46美元。分析人士預計,西部醫藥服務公司本年度每股收益將達到9.09美元。

West Pharmaceutical Services Company Profile

西部醫藥服務公司簡介

(Get Rating)

(獲取評級)

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.

西方製藥服務公司在美洲、歐洲、中東、非洲和亞太地區設計、製造和銷售可注射藥物和保健產品的容器和輸送系統。它分為兩個部分,專有產品和合同製造產品。

Featured Articles

專題文章

  • Get a free copy of the StockNews.com research report on West Pharmaceutical Services (WST)
  • 3 Airline Stocks Stuck in a Holding Pattern
  • Roku Stock is Down but Not Out
  • If You're Hungry for Value, Take a Bite on Ruth's Hospitality Grp
  • Is Ford Rolling To A Rebound After Its Q3 Warning
  • Has AMD stock stock fallen too far?
  • 免費獲取StockNews.com關於West Pharmtics Services(WST)的研究報告
  • 3家航空公司股票陷入持有格局
  • Roku股票下跌,但並未出局
  • 如果你渴望價值,那就嚐嚐露絲的好客之道吧
  • 福特在第三季度發出警告後是否正在反彈
  • AMD股票是不是跌得太厲害了?

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating).

想看看還有哪些對衝基金持有WST嗎?訪問HoldingsChannel.com獲取西方製藥服務公司(紐約證券交易所代碼:WST-GET Rating)的最新13F文件和內幕交易。

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.

接受《西部醫藥服務報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對West Pharmtics Services和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論